Two Sigma Advisers
PASG icon

Two Sigma Advisers’s Passage Bio PASG Stock Holding History

Two Sigma Advisers’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,480
Closed -$283K – 2622
2024
Q1 		$283K Sell
10,480
-45
-0.4% -$1.08K ﹤0.01% 2092
2023
Q4 		$213K Sell
10,525
-1,485
-12% -$20.5K ﹤0.01% 2207
2023
Q3 		$158K Sell
12,010
-375
-3% -$6.16K ﹤0.01% 2140
2023
Q2 		$233K Sell
12,385
-3,140
-20% -$62.1K ﹤0.01% 2056
2023
Q1 		$297K Sell
15,525
-6,480
-29% -$176K ﹤0.01% 2145
2022
Q4 		$607K Sell
22,005
-3,455
-14% -$87.2K ﹤0.01% 1802
2022
Q3 		$637K Sell
25,460
-3,590
-12% -$141K ﹤0.01% 1741
2022
Q2 		$1.37M Buy
29,050
+2,835
+11% +$132K ﹤0.01% 1424
2022
Q1 		$1.63M Buy
26,215
+4,665
+22% +$384K ﹤0.01% 1374
2021
Q4 		$2.74M Buy
21,550
+13,625
+172% +$2.22M 0.01% 1039
2021
Q3 		$1.58M Buy
7,925
+6,340
+400% +$1.51M ﹤0.01% 1381
2021
Q2 		$420K Buy
+1,585
New +$490K ﹤0.01% 2019

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Advisers's PASG Position: Q2 2024 in Review

Two Sigma Advisers sold out of Passage Bio (PASG) in Q2 2024, closing a stake of 10,480 shares — an estimated $283K sold.

Two Sigma Advisers first reported a position in PASG in Q2 2021 and held it in 12 quarters. The position peaked at $2.74M in Q4 2021. 43 funds tracked by Wall St. Rank hold PASG as of Q2 2024.

  • Two Sigma Advisers reported no remaining Passage Bio position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 10,480 Passage Bio shares in Q2 2024, an estimated $283K.
  • Two Sigma Advisers first reported a position in Passage Bio in Q2 2021 and held it in 12 quarters.
  • Two Sigma Advisers's Passage Bio position peaked at $2.74M in Q4 2021.
  • 43 funds tracked by Wall St. Rank held Passage Bio as of Q2 2024.

Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.